{"name":"Ampel BioSolutions, LLC","slug":"ampel-biosolutions-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RAYOS","genericName":"RAYOS","slug":"rayos","indication":"Rheumatoid arthritis","status":"marketed"}]}],"pipeline":[{"name":"RAYOS","genericName":"RAYOS","slug":"rayos","phase":"marketed","mechanism":"RAYOS is a delayed-release formulation of prednisone that releases the corticosteroid in the colon to provide anti-inflammatory effects with reduced morning cortisol suppression.","indications":["Rheumatoid arthritis","Polyarticular course juvenile idiopathic arthritis","Psoriatic arthritis","Ankylosing spondylitis","Systemic lupus erythematosus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPX3BXTHZiYVJhZGV6b3JScVo4RHFQWkI2Qk9YYldxaExwN04tbXNrNWp2RXhzSHFwYVo0aU81OS1PTHRMSFhxWVZZNFJZXzBsWGlpcGV0b0dIZEl4Z0ZXcTFUeW1LR2xPYlVDLV81TW9vSkR3N0M0OWVRVndJalhWejliMVlJRmhlZmczQ1VsRVV1bU4ySGNTel9Db1YzVlJBMHRVcW1BZGZVZF9O?oc=5","date":"2022-09-23","type":"pipeline","source":"BioWorld News","summary":"Ampel’s genomic blood test detects and predicts severity of COVID-19 - BioWorld News","headline":"Ampel’s genomic blood test detects and predicts severity of COVID-19","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}